Show results for
Refine by
Approved Peptide Drugs Equipment & Supplies In Palau
42 equipment items found
Manufactured by:Beldimed s.a. based inAndrimont, BELGIUM
The expression “Patient First” is part of our DNA. We truly believe that every person in the world should have the same opportunities when it comes to healthcare because health is the ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Dalbavancin (INN, trade name Dalvance) is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin.The Food and Drug Administration approved dalbavancin for the treatment of acute bacterial skin and skin structure infections caused by certain susceptible bacteria.https://www.creative-peptides.com/product/dalbavancin-item-10-101-78-32.html ...
Manufactured by:RareStone Group based inShanghai, CHINA
WAKIX® (pitolisant) is a narcolepsy treatment that Citrine has in-licensed from the French biotech company, Bioprojet, for use in China. Pitolisant is a selective histamine H3-receptor antagonist/inverse agonist, which increases the release of the brain chemical histamine to increase a patient's wakefulness and alertness. The drug was approved by the European Medicines Agency (EMA) in 2016 ...
Manufactured by:Amivas (US), LLC based inFrederick, MARYLAND (USA)
Artesunate for Injection is an antimalarial indicated for the initial treatment of severe malaria in adults and ...
Manufactured by:BioQ Pharma based inSan Francisco, CALIFORNIA (USA)
invenious connect-and-go technology is already being used to deliver infusibles in a patented range of infusion systems. Our products are thoughtfully-designed to each drug – with bespoke solutions for: Drugs requiring complex weight-based dosing. Cytotoxic drugs. Drugs that need to be reconstituted or diluted at time of use. Drug-drug combinations, including for cold-chain ...
Manufactured by:Cellworks Research India Private Limited based inBangalore, INDIA
The Cellworks Platform biosimulates how a patient’s unique cancer will respond to therapies prior to treatment and identifies novel drug combinations for treatment-refractory patients. Therapy biosimulation is the ability to predict the phenotype response of a human cell to an external stimulus, such as a drug ligand or radiation. We utilize this technology, to determine a patient’s ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines has developed VesiculoVax™-vectored vaccines for pre- and post-exposure protection against the hemorrhagic disease caused by multiple species of filovirus (i.e. Zaire ebolavirus, Sudan ebolavirus and Marburg ...
Manufactured by:Quanterix Corporation based inBillerica, MASSACHUSETTS (USA)
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex circulating biomarker detection at the earliest stages of disease progression - even at healthy baseline levels. The Quanterix SP-X Imaging and Analysis System is a complete benchtop system that offers true multiplex detection at both acute and baseline levels. For the first time, oncology and ...
Manufactured by:KORU Medical Systems based inMahwah, NEW JERSEY (USA)
With the performance of the familiar FREEDOM60® in an even simpler design for 20ml and 30ml syringes comes the FreedomEdge® – a compact infusion solution that’s easy to use for smaller or often-repeated doses. It is so simple it makes frequent and flexible dosing a reality – in a safe, controlled manner. Just close and go. ...
Manufactured by:Catalent, Inc based inSomerset, NEW JERSEY (USA)
GPEx cell line development technology is a proven technology that generates high-performance, highly stable, production cell lines. Virtually any cDNA (mAb and multigenic applications) can be inserted into cells. To date, over 600 different mAb and mAb fusions and over 160+ different recombinant proteins have been produced using the GPEx system, with 160+ clinical trials utilizing therapeutic ...
Manufactured by:AllCells based inAlameda, CALIFORNIA (USA)
AllCells’ GMP Mobilized leukopaks are apheresis products collected from healthy donors treated with FDA-approved drugs to stimulate mobilization of CD34+ hematopoietic stem and progenitor cells from the bone marrow to the peripheral blood. This procedure results in large-scale yields of CD34+ cells. Peripheral blood is collected from IRB-consented donors using the continuous flow Spectra ...
by:Pureims B.V. based inRoden, NETHERLANDS
Amikacin Cyclops™ is an amikacin dry powder inhaler for the treatment of tuberculosis (TB). Inhaled amikacin from the Cyclops™ will result in higher amikacin concentrations in the lungs than conventional infusion or intramuscular injection. This could more rapidly decrease contagiousness by sterilizing the upper airways of patients with ’open’ (smear positive) TB, ...
Manufactured by:Premier Biotech, Inc. based inMinneapolis, MINNESOTA (USA)
Premier Biotech’s CLIA-Waived (Clinical Laboratory Improvement Amendments) multi-drug integrated cup and dip products offer the ability to test for 5-14 drugs. CLIA-Waived test products are cleared by the FDA for over-the-counter (OTC) use, suited for workplace and clinical drug testing programs and approved for waiver under the CLIA ...
Manufactured by:AllCells based inAlameda, CALIFORNIA (USA)
Mobilized Leukopaks are apheresis products collected from healthy donors treated with FDA-approved drugs to stimulate the migration of CD34+ hematopoietic stem and progenitor cells (HSPCs) from the bone marrow niche into the circulation. Mobilized peripheral blood, enriched in single-donor CD34+ HSPCs is collected through leukapheresis using the Spectra Optia® Apheresis System’s ...
Manufactured by:BRIM Biotechnology, Inc. based inTaipei City, TAIWAN
Neurotrophic Keratitis is a rare, degenerative disease characterised by corneal sensitivity reduction, spontaneous epithelium breakdown, and impairment of corneal healing. Currently, there is only one drug, Oxervate (Cenegermin), approved by the US FDA and EMA in 2018. Eye health is crucial to quality of life and BRIM is advancing new therapeutics to support patients affected by Neurotrophic ...
Manufactured by:Biosceptre International Limited based inCambridge, UNITED KINGDOM
We are also developing antibodies that specifically target nfP2X7 for use in both solid and haematological tumours. Our preclinical data is very promising and studies show an excellent safety profile. By exploiting the modular nature of the antibody structure, the same panel of antibody sequences can be used to generate a variety of therapeutic antibody formats including, but not limited to, ...
Manufactured by:KORU Medical Systems based inMahwah, NEW JERSEY (USA)
Safety meets simplicity at last in a pump designed for everyone: patients, nurses, pharmacists, and technicians. The syringe driver is designed to accommodate 60ml, now labeled 50 ml, BD ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
The emerging global threat from COVID-19 demanded immediate action. With cases rising rapidly, we set up a specialist team to use our AI-drug discovery platform to search for existing drugs — already proven safe — that could be repurposed to treat the virus. We are the only AI company to successfully identify a drug to treat COVID-19. Together by building bespoke drug repurposing ...
by:ImageProVision Technology Pvt. Ltd. based inPune, INDIA
The ipvPClass is an advanced Microscopic Image Analysis system designed to streamline the characterization of particulate solids. Equipped with a high-resolution camera and dedicated software, it integrates seamlessly with any standard microscope, providing detailed analyses based on particle size, shape, and texture. This system improves the accuracy and efficiency of microscopic particle ...
Manufactured by:Cerevast Medical, Inc. based inBothell, WASHINGTON (USA)
When a blood clot or thrombus is formed, strands of fibrin anchor one red blood cell to another. It is these fibrin strands that form the lattice or structural matrix of the blood clot. The formation or deposition of these clots in the arterial vessels of the brain is one of the primary causes of ischemic stroke. Intravenous thrombolytic therapy (tPA/alteplase, the only approved drug for the ...